| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794529 | Ophthalmology Retina | 2018 | 8 Pages |
Abstract
More than half of patients with nAMD treated with anti-VEGF injections for 4 years developed new MA. Atrophy progression was most strongly correlated with age, which suggests that baseline disease characteristics may be more predictive of MA progression than cumulative anti-VEGF treatment.
Keywords
CNVCATAMDRPECATTSpectral domain OCTnAMDSD-OCTCStChoroidal neovascularizationMacular atrophyretinal pigment epitheliumMacular volumeneovascular age-related macular degenerationage-related macular degenerationcentral subfield thicknessVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ang MD, Nathaniel B. BS, Felipe F. MD, Fabiana Q. MD, Jonathan E. MD, Sunil MD, Justis P. MD, Andrew P. MD, Amy S. MD, Peter K. MD, Daniel F. MD, Rishi P. MD,